Cargando…
Discovery and preclinical development of new antibiotics
Antibiotics are the medical wonder of our age, but an increasing frequency of resistance among key pathogens is rendering them less effective. If this trend continues the consequences for cancer patients, organ transplant patients, and indeed the general community could be disastrous. The problem is...
Autores principales: | Hughes, Diarmaid, Karlén, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034554/ https://www.ncbi.nlm.nih.gov/pubmed/24646082 http://dx.doi.org/10.3109/03009734.2014.896437 |
Ejemplares similares
-
Environmental and genetic modulation of the phenotypic expression of antibiotic resistance
por: Hughes, Diarmaid, et al.
Publicado: (2017) -
The global preclinical antibacterial pipeline
por: Theuretzbacher, Ursula, et al.
Publicado: (2019) -
Towards the sustainable discovery and development of new antibiotics
por: Miethke, Marcus, et al.
Publicado: (2021) -
Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives
por: Padia, Janak, et al.
Publicado: (2020) -
Discovery and Preclinical Work
por: Mochly-Rosen, Daria, et al.
Publicado: (2013)